Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07827742 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Rituximab vs Placebo for Maintenance in Systemic Sclerosis - Interstitial Lung Disease

Name: Rituximab vs Placebo for Maintenance in Systemic Sclerosis - Interstitial Lung Disease — clinical trial record (NCT07827742)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MAINRITSyS

StatusNot Yet Recruiting

PhasePhase 2

SponsorAssistance Publique - Hôpitaux de Paris

Started2026-10

View on ClinicalTrials.gov ↗

Assistance Publique - Hôpitaux de Paris

1,338 trials monitored

See 38 trials at risk

Scleroderma

302 trials monitored

See 9 trials at risk

The purpose of this study is to determine whether Rituximab is safe and effective as a maintenance strategy in individuals with stabilized systemic sclerosis in adults.

Trial Details

NCT Number	NCT07827742
Lead Sponsor	Assistance Publique - Hôpitaux de Paris Collaborators: URC-CIC Paris Descartes Necker Cochin
Conditions	Systemic Sclerosis in Adults
Enrollment	120 participants
Start Date	2026-10
Primary Completion	2030-05 (estimated)
Study Completion	2031-03 (estimated)
Updated on ClinicalTrials.gov	2026-09-18